Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population
Open Access
- 25 June 2019
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 7 (2), 1-5
- https://doi.org/10.14218/JCTH.2018.00048
Abstract
Background and Aims: Fatty infiltration of liver may induce insulin resistance (IR), and a proportion of patients with nonalcoholic fatty liver disease (NAFLD) is diagnosed with nonalcoholic steatohepatitis. Transient elastography is gaining popularity as a means of non-invasively determining both liver stiffness (fibrosis level) and degree of fatty infiltration, expressed as controlled attenuation parameter (CAP) value.Keywords
This publication has 35 references indexed in Scilit:
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseJournal of Hepatology, 2017
- Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey DataThe American Journal of Gastroenterology, 2017
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisJournal of Hepatology, 2016
- Non-invasive diagnosis of hepatic steatosisHepatology International, 2016
- NAFLD and diabetes mellitusNature Reviews Gastroenterology & Hepatology, 2016
- Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseWorld Journal of Hepatology, 2015
- Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinationsJournal of Hepatology, 2014
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various CausesJapanese Journal of Clinical Oncology, 2010
- Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis CJournal of Hepatology, 2007